Artax Biopharma Expands Company’s Scientific Advisory Board and Welcomes James G. Krueger, M.D., Ph.D., and Ajay Nirula, M.D., Ph.D., Both Experts in T-Cell-Mediated DiseasesYou must be logged in to view this page.
Novo Holdings and Sound Bioventures launch Breye Therapeutics to develop novel oral therapies for ophthalmologic diseasesYou must be logged in to view this page.
Johan Kördel is interviewed about Sound Bioventures and its Investment Strategy by BioStockYou must be logged in to view this page.
Johan Kördel appears on DI TV stating that “the time to invest in Biotech is now”!You must be logged in to view this page.
Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated DiseasesYou must be logged in to view this page.
Broad Media Coverage of the launch of Sound Bioventures Fund IYou must be logged in to view this page.
Sound Bioventures raises € 110 million for new biotherapeutics venture fundYou must be logged in to view this page.